Search Results (94)

Background and Objectives: There is a lack of information on the dietary intake of long-term combined oral contraceptive users (COC-users) in relation to their body composition. The aim of the pilot study was to determine the food consumption of young women using COCs for >6 months and its relationship to body composition compared to non-users. Materials and Methods: A total of 45 healthy women (21.8 ± 1.7 years) were divided into COC non-users (n = 19) and users of a low (≤20 μg) ethinylestradiol (EE) dose (n = 18) and a medium (30–35 μg) EE dose (n = 8). Anthropometric data, body composition, physical activity levels, three-consecutive-days of dietary records, and serum concentrations of calcium, magnesium, and vitamin D were assessed. Statistical methods included chi-squared, Fisher’s exact test, t-test, Mann–Whitney U test, Spearman’s correlation, and multiple linear regression. Results: There were no differences between COC-users and non-users in terms of physical activity, intake of micronutrients, body mass index, body fat percentage (BF%), or bone mineral density (BMD). COC-users consumed a higher percentage of energy from fats (p = 0.02) and had higher serum vitamin D levels (p < 0.01). BF% was negatively associated with BMD (coefficient −0.008; p = 0.027). Conclusions: The use of COCs for ˃6 months is not associated with FM or BMD, regardless of dietary differences. Further attention should be paid to possible associations between COCs use, dietary habits, and body composition (including BMD). Full article

The present study targets key limitation ‘separation after the process’ that is responsible for the loss of the photocatalyst in water treatment during heterogeneous photocatalysis. Therefore, eco-friendly nanostructured ZnO coatings were engineered by the doctor blade technique through the immobilization of green ZnO nanomaterials onto alumina substrate. ZnO/BPE 30 and ZnO/BPE 60 coatings were obtained from banana peel extract-based ZnO powder (ZnO/BPE). Likewise, ZnO/GTE 30 and ZnO/GTE 60 were prepared using green tea extract-based ZnO powder (ZnO/GTE). XRD characterization verified hexagonal wurtzite ZnO phase, while HRSEM analysis revealed that the flat surface of ZnO/BPE had rod-like nanostructures below 120 nm, and ZnO/GTE had spherical, porous nanoparticle networks with less than 70 nm. According to UV–vis spectrometry, all four coatings have bandgaps of ~5 eV. The highest efficiency for the solar-driven photocatalytic degradation of emerging organic pollutants was for ciprofloxacin (among pesticides clomazone and tembotrione; pharmaceuticals ciprofloxacin and 17α-ethinylestradiol; and mycotoxin zearalenone) in ultrapure water with the presence of all studied ZnO-based coatings, after 60 min of simulated solar irradiation. Its highest removal (89.1%) was achieved with ZnO/GTE 30, also having good reusability across three consecutive cycles in river water, thus supporting the application of eco-friendly, immobilized ZnO nanomaterials for wastewater treatment and environmental remediation. Full article

The widespread presence of estrogenic pollutants in aquatic environments poses a significant threat to ecosystems and human health, necessitating the development of efficient and sustainable removal technologies. This study aimed to develop a cost-effective biocatalyst for estrogen biodegradation using a fungal laccase. The enzyme was produced by the native strain Dichostereum sordulentum under semi-solid-state fermentation conditions optimized using a statistical Design of Experiments. The design evaluated carbon sources (glucose/glycerol), nitrogen sources (peptone/urea), inoculum size, and Eucalyptus dunnii bark as a solid support/substrate. The resulting laccase was entrapped within a hydrogel made of lignocellulosic biopolymers derived from a second-generation bioethanol by-product. Maximum laccase production was achieved with a high concentration of peptone (12 g/L), a low amount of bark (below 2.8 g), 8.5 g/L glucose and 300 mg/flask of inoculum. The subsequent immobilized laccase achieved 98.8 ± 0.5% removal of ethinylestradiol, outperforming the soluble enzyme. Furthermore, the treatment reduced the estrogenic biological activity by more than 170-fold. These findings demonstrate that the developed biocatalyst not only valorizes an industrial by-product but also represents an effective and sustainable platform for mitigating hazardous estrogenic pollution in water. Full article

The widespread presence of estrogens in aquatic environments represents a One Health concern, as it simultaneously threatens environmental integrity, wildlife health, and human well-being. These compounds, widely used in human and veterinary medicine, are excreted in partially or unmetabolized forms and persist in the environment due to the inefficiency of conventional water treatment systems in removing them. This systematic review provides a global overview of the occurrence of estrogens in water resources. We synthesized data on study characteristics, estrogen compounds detected, their concentrations, types of water bodies, and geographic locations. In total, 39 estrogens, including natural, synthetic, and metabolite forms, were reported at concentrations ranging from 0.002 to 10,380,000.0 ng/L across 40 water body types in 59 countries on all continents. The most frequently detected compounds were estrone, estradiol, and ethinylestradiol. Estrogens were predominantly identified in wastewater treatment plant effluents, rivers, lakes, surface waters, and even drinking water sources. These findings underscore the estrogen contamination and its potential to disrupt endocrine functions across species, posing serious implications for ecosystems. Within the One Health framework, this review highlights the urgent need for integrated strategies to improve water quality monitoring, develop advanced treatment technologies, and update regulatory standards to address the multifaceted risks posed by estrogenic contaminants. Full article

In this study, we developed a tapered optical fiber sensor enhanced with carbon quantum dots (CQDs) for the detection of 17-α-ethinylestradiol (EE2). The sensor operates on the changes in refractive index induced by the interaction between EE2 and antibodies on its surface. The incorporation of CQDs significantly increased the available surface area for receptor–analyte interactions, leading to enhanced sensor performance. The sensor demonstrated high sensitivity of 2.4925 nm/(ng/L) within a detection range of 1 to 10 ng/L, with a strong correlation coefficient (R² = 0.998). A detection limit as low as 0.0426 ng/L (0.144 pM) was achieved, along with a low dissociation constant of 2.19 × 10⁻¹¹ M as determined by the Langmuir isotherm model. These findings highlight the potential of the CQD-functionalized optical fiber sensors as a promising tool for sensitive and selective EE2 detection in environmental monitoring applications. Full article

Global warming raises surface water temperatures, impacting fish alongside pollutants, such as ubiquitous xenoestrogens. Combined stressor effects are poorly studied but likely to worsen impacts and hinder biota adaptation, warranting further research. Unadapted fish face heightened risks. The liver is a vital metabolic organ, sensitive to temperature and xenoestrogens, eventually adjusting hepatocyte size and number to ensure survival, growth, and reproduction. This study assessed, for the first time, the impact of exposure (45 days) to thermal stress (29 °C versus 26 °C) and ethinylestradiol (EE2, 5 ng/L) on male guppies, primarily on body and quantitative liver morphology. Higher temperature reduced body mass (14%) and standard length (3.6%) gain. EE2 exposure reduced body mass increase (14%), hepatosomatic index (20%), and the volumes of the liver (32%), hepatocytes (16%), and their nuclei (17%). The nucleus-to-cytoplasm ratio and total hepatocyte number remained stable. No histopathological lesions existed. Guppies appear to have adapted to stressors by reducing hepatocyte size and utilizing lipid reserves, yet they exhibited deficits in body growth and hepatosomatic index. Gonadal maturation was unaffected. Only under EE2 at 29 °C did hepatocytes show minimal lipid droplet content (less vacuolation). This indicated exhausted reserves, reinforcing how heat and toxicants interact to exacerbate impacts. Full article

The increasing presence of emerging contaminants in aquatic environments, particularly endocrine disruptors (EDs), has raised significant environmental and public health concerns due to their toxicity, persistence, and ability to interfere with the endocrine systems of both aquatic organisms and humans. Among these compounds, the steroid hormones 17β-estradiol (E2) and 17α-ethinylestradiol (EE2) stand out, as they are frequently detected in wastewater, even after conventional treatment processes, which often exhibit limited removal efficiency. In this context, advanced oxidation processes (AOPs), especially those based on the generation of sulfate radicals (SO₄•⁻), have emerged as promising alternatives due to their high redox potential, extended half-life, and broad effectiveness across various pH levels. This work reviews recent advances in AOPs for the degradation of E2 and EE2, focusing on sulfate radical-based processes. The main degradation mechanisms, operational parameters, removal efficiency, challenges for large-scale application, and gaps in the current literature are discussed. The analysis indicates that despite their high effectiveness, sulfate radical-based processes still require further investigation in real wastewater matrices, the assessment of the toxicity of by-products, and the optimization of operational variables to be established as viable and sustainable technologies for wastewater treatment. Full article

Steroid hormones are micropollutants that contaminate water worldwide and have significant impacts on human health and the environment, even at very low concentrations. The aim of this article is to provide an overview of technologies for the removal of endocrine-disrupting compounds with a focus on oestrogens (estrone E1, 17β-oestradiol E2, estriol E3), the synthetic oestrogen (17α-ethinylestradiol EE2 and bisphenol A BPA), and pharmaceuticals found in wastewater. Hormonal and pharmaceutical contaminants are mostly persistent organic compounds that cannot be easily removed using conventional wastewater treatment processes. For this reason, researchers have tried to develop more efficient tertiary wastewater treatment technologies to reduce micropollutant concentrations in wastewater. This review covers the following processes: Advanced oxidation, nanofiltration, ultrasound, electro-Fenton processes, electrolysis, adsorption, ozonation, photolysis, photocatalysis, ultrafiltration, and electrocoagulation. Attention was paid to the effectiveness of the processes in terms of eliminating hormones and pharmaceuticals from wastewater, as well as on economic and environmental aspects. The combination of different processes can be a promising treatment scheme for retaining and degrading hormonal and pharmaceutical compounds from wastewater. With hybrid technologies, the advantages of the methods are combined to maximise the removal of pollutants. However, optimal methods of wastewater treatment depend on the quality and quantity of the wastewater, as well as the residual hormonal and pharmaceutical compounds and their hazardous effects. Full article

Background/Objectives: Endometriosis can present as ovarian endometriosis in 15–25% of the cases. While chronic pelvic pain and dysmenorrhea dominate its clinical presentation, acute complications, such as spontaneous OMA rupture, are rare (<3%), often mimicking acute abdominal pain and necessitating emergency surgery. Diagnostic delays persist due to the condition’s rarity and overlapping symptoms with ovarian torsion or appendicitis. This study investigates the clinical features of ruptured OMAs to enhance preoperative suspicion and optimize management. Methods: From February 2011 to August 2023, 14 patients with spontaneous rupture of histologically confirmed endometriomas underwent emergency laparoscopy for acute abdominal pain in the University Hospital of Bern, Switzerland. The clinical data of these patients were analyzed to find common patterns of spontaneous endometrioma ruptures. We also conducted a literature search in PubMed, Scopus, ScienceDirect, Cochrane, and Embase databases from inception to December 2023 in order to identify other possible confounding factors. The search was based on the keywords “ruptured endometrioma”. All English full-text prospective and retrospective observational and interventional studies with at least five patients that described the clinical features and findings of women diagnosed with ruptured endometrioma and treated surgically were included. Results: The median age at operation was 37.4 (23–49) years old, and all cases presented with acute abdominal pain, with/without peritonitis. Only 3/14 patients presented with fever, while the most common laboratory finding was an elevated CRP level of 45.6 mg/L (3–100 mg/L), while leukocytosis was less pronounced, with a median of 12.2 G/L (6.04–21.4 G/L). Notably, 64.3% (9 out of 14) of the patients reported experiencing dysmenorrhea, while for the remaining 5 individuals, the presence or absence of dysmenorrhea could not be obtained. Interestingly, only one patient had undergone hormonal treatment, with a combined oral contraceptive (COC) of Ethinylestradiol (0.02 mg) and Desogestrel (0.15 mg), while the other patients either lacked awareness of their endometriosis or expressed reluctance towards hormonal downregulation therapy. The median endometrioma size was 7 cm (3.5–18 cm), and 78.57% of the cases (11 out of 14 patients) had only ovarian endometriosis, while only 3 patients had involvement of compartment A, B, or C according to the # ENZIAN classification. Conclusions: Though rare, spontaneous OMA rupture should be considered in acute abdomen cases, especially with cysts > 5 cm. Hormonal therapy may reduce rupture risk, but more research is needed to confirm this and refine diagnostic strategies. Full article

The assessment of surface water quality of the Danube River and Black Sea was performed taking into account the amounts determined for heavy metals (As, Cd, Cr, Cu, Hg, Mn, Ni, Pb, Zn), nutrients (compounds of N and P, chlorophyll a), emerging contaminants (CECs) (pharmaceutics and endocrine disruptors—19 quantified compounds, out of 30 targeted chemicals), heterotrophic bacteria and total coliforms, in thirty-two locations from the lower Danube sector (starting with km 375 up to the river mouths), the Danube Delta Biosphere Reserve (three Danube branches—Chilia, Sulina, and Sf. Gheorghe) and the Romanian coastal area of the Black Sea. The heavy metals levels were found in the following ranges: 3.0–6.5 μg/L As; 0.51–1.32 μg/L Cd; 21.6–61.2 μg/L Cr; 10.2–28.6 μg/L Cu; 196–351 μg/L Mn; 12.3–47.67 μg/L Ni; 5.2–15.5 μg/L Pb; 44–74 μg/L Zn; 0.01–0.08 μg/L Hg. The nutrient concentrations vary in the intervals: 0.04–0.45 mg/L N-NH₄; 0.01–0.06 mg/L N-NO₂; 0.07–1.9 mg/L N-NO₃; 1.0–3.2 mg/L N total; 0.01–0.05 mg/L P-PO₄; 0.02–0.27 mg/L P total, and 0.8–17.3 μg/L chlorophyll a. The concentrations of CECs from various classes (sulfamethoxazole, trimethoprim, ciprofloxacin, flumequine, amoxicillin, cefuroxime, dicloxacillin, carbamazepine, pravastatin, erythromycin, piroxicam, ketoprofen, diclofenac, naproxen, enilconazole (imazalil), clotrimazole, drospirenone, 17α-ethinylestradiol, and bisphenol A) were compared with values reported for European rivers and the Danube River water in various river sectors. The highest detection frequencies were registered for bisphenol A (100%), sulfamethoxazole (96%), carbamazepine and diclofenac (87%), trimethoprim (78%), pravastatin (46%), and imazalil (34%). Bisphenol A exhibited the largest concentrations (342 ng/L), followed by diclofenac (132 ng/L), carbamazepine (38 ng/L), and sulfamethoxazole (36 ng/L). For most of the contaminants, Black Sea coastal water showed lower concentrations than the Danube water and good ecological status for surface water. Correlations between CECs and total coliforms suggest insufficient treated wastewater effluents as a common contamination source and possible use of CECs as indirect fecal pollution indicator in aquatic systems. This is the first study carried out in the connected system Danube River–Danube Delta–Black Sea for a large palette of toxicants classes and microbial pollutants, which will serve as a baseline for future monitoring of water quality in the region. Full article

Background: Medicines affect the environment throughout their lifecycle, from production and distribution to use and disposal. They contribute to the pollution of air, water, and soil, impacting ecosystems and human health. Recognizing these risks, regulatory bodies and organizations have highlighted pharmaceutical pollution as a global concern, emphasizing the need for environmental risk assessments and sustainable practices. Methods: This study reviewed the essential medicines lists (EMLs) from 158 countries and examined the available ecotoxicological data. Medicines with high bioaccumulation, persistence, and toxicity were identified and cross-referenced with their inclusion in EMLs. Additionally, we analyzed the presence of alternative medicines with similar therapeutic effects but potentially lower environmental risks. Results: Five medicines—ciprofloxacin, ethinylestradiol, levonorgestrel, ibuprofen, and sertraline—were selected as illustrative examples due to their high environmental persistence and toxicity. All were listed in the 2023 WHO model list, with ciprofloxacin appearing in 94.3% of national EMLs. Conclusions: This study underscores the limited availability of ecotoxicological data, which hinders environmental risk assessment for medicines. EMLs could serve as a tool to enhance the awareness and data mobilization of pharmaceutical pollution. Incorporating environmental criteria into EMLs could support more sustainable medicine selection and regulatory practices. Full article

Endocrine disruptors such as 17α-ethinylestradiol pose significant ecological risks in aquatic environments. This study assessed the catalytic performance of Fe- and Cu-impregnated delaminated clays (DCs) and layered double hydroxides (LDHs) in a Fenton-like process for EE2 removal. The effects of key parameters—including hydrogen peroxide concentration, initial contaminant load, and catalyst dosage—were analyzed using HPLC-QqTOF. Delaminated clays (DCs) demonstrated higher removal efficiencies compared to layered double hydroxides (LDHs), reaching 55% with Fe and 47% with Cu, while LDHs achieved 40% and 33% for Fe and Cu, respectively. Ecotoxicity was evaluated using bioassays (L. sativa, S. capricornutum, D. magna) and the Ames test. Notably, S. capricornutum exhibited 100% inhibition at the highest tested concentration, with IC₅₀ values of 11.2–12.4 for Cu and 31.5–32.7 for Fe. L. sativa was inhibited by Cu- and Fe-impregnated LDH/DC, with IC50 values of 71.0 (DC-Cu), 56.6 (DC-Fe), and 58.6 (LDH-Fe). D. magna exhibited 17–75% mortality when exposed to untreated EE2, while LC50 values confirmed Cu’s greater toxicity. The Ames test indicated no mutagenic effects. Integrating the Fenton-like process with complementary techniques is recommended to enhance efficiency. These findings highlight the need to optimize operational parameters for effective removal of 17α-ethinylestradiol. Full article

Among several types of emerging contaminants, the endocrine disruptors 17β-estradiol (E2) and 17α-ethinylestradiol (EE2) are particularly notable. These compounds are discharged into sewage systems and subsequently into water bodies, as conventional wastewater treatment processes are unable to effectively eliminate such pollutants. Therefore, the present study aimed to evaluate the possibility of removing the endocrine disruptors 17β-estradiol (E2) and 17α-ethinylestradiol (EE2) from water using the photocatalytic activity of the compound Ag₃AsO₄. Silver arsenate was synthesized and characterized, the quantification of the hormones E2 and EE2 was achieved by high-performance liquid chromatography with a fluorescence detector, and a validation process and some preliminary tests were performed on the photodegradation of the hormones using the Ag₃AsO₄ catalyst. Validation was performed, and satisfactory results were achieved: r = 0.9987 (E2), r = 0.9984 (EE2), a detection limit of 5.01 (E2) and 0.51 (EE2), a quantification limit of 15.19 (E2) and 1.54 (EE2), coefficients of variation for precision intraday and interday lower than 10.9725% and 11.3393%, respectively, and a recovery of 100.15% (E2) and 100.31% (EE2). In photodegradation studies, Ag₃AsO₄ showed different behavior in the presence of light for each hormone. In solution with E2, it reached a removal rate of 35% of the hormone under LED light, acting as a photocatalyst, while with EE2, it reached a removal rate of 96%; both results were obtained after 30 min of exposure to visible light. When this study is compared with other processes and materials, the high efficiency of the Ag₃AsO₄ photocatalyst in removing E2 and EE2, persistent emerging contaminants, becomes evident. This advancement has significant implications for wastewater treatment, offering a promising solution that can mitigate environmental impacts caused by endocrine disruptors. Full article

Estrogens in aquatic environments pose significant ecological and health risks due to their cumulative effects rather than individual impacts. This study investigates the voltammetric behavior of estrone (E1), 17β-estradiol (E2), estriol (E3), and 17α-ethinylestradiol (EE2), presenting a cost-effective and straightforward method for their simultaneous determination. Using differential pulse voltammetry (DPV) with a boron-doped diamond electrode, the method demonstrates high precision (deviations under 4%) and a linear dynamic range of 15.35–134.55 µmol·L⁻¹. Integration of a vacuum evaporation step reduced detection limits to 10⁻⁸ mol·L⁻¹, enabling effective analysis of real water samples. This optimized approach ensures practical applicability for monitoring total estrogen content in aquatic systems, providing an accessible and reliable alternative to conventional methods. Full article

A method for identifying six estrogen preparations by thin-layer chromatography combined with Raman imaging microscopy (TLC-RIM) was established. An appropriate pretreatment method was adopted to extract and purify the six estrogen preparations. After that, each estrogen extraction solution was spotted on a thin-layer chromatography plate. Estriol (E3), estradiol (E2), estradiol valerate (EV), estradiol benzoate (EB), nilestriol (CEE), and ethinylestradiol (EE2) were separated by TLC, and their R_f value and localization were determined under a UV lamp at 254 nm, followed by the in situ enrichment of the drug component. Using a 532 nm laser as the light source, the Raman scattering spectrum of the component was directly collected by micro-Raman imaging. The R_f values after TLC separation of the six estrogens and their Raman spectra can, respectively, reflect differences in polarity and structure, and they are not affected by the excipients of preparation. The detection limits of the six estrogens are 0.636, 1.00, 0.687, 0.497, 0.649, and 0.626 mg/mL. Based on the intensity of the minimum characteristic peak, the stability results within 40 min showed that the RSD of each substance is 1.34, 2.06, 1.65, 3.99, 1.16, and 2.71%, respectively. This method has strong specificity, good stability, and high sensitivity, and it can provide a new reference for improving the identification standards of estrogen preparations. Full article